drugset / Trial / NCT00236379

A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder

NCT00236379

Phase 4 Completed 59 enrolled Janssen, LP
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess and compare how risperidone and olanzapine, two antipsychotic medications, affect the regulation of glucose (sugar) in the body.

Timeline

Start
Primary completion
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule 20 mg Oral
Subject Risperidone Other / unclassified 6 mg Oral